In8Bio (INAB) Net Equity Issued and Repurchased (2020 - 2025)
In8Bio (INAB) reported Net Equity Issued and Repurchased of $10.04 million for Q4 2025, up 61.5% from $6.22 million a year earlier and up 802.6% from the prior quarter.
Powered by 
Analysis
In8Bio (INAB) Net Equity Issued and Repurchased (2020 - 2025) Analysis & Trends
For FY2025, In8Bio posted Net Equity Issued and Repurchased of $18.5 million, up 202.0% from FY2024.
- Net Equity Issued and Repurchased has a five-year compound annual growth rate of 106.0% (FY2020 to FY2025).
- By year, Net Equity Issued and Repurchased came in at $6.13 million in FY2024 (-57.4%), $14.38 million in FY2023 (+50.7%), $9.54 million in FY2022 (-73.7%) and $36.33 million in FY2021.
- The Q4 2025 figure ranks as the highest quarterly Net Equity Issued and Repurchased since Q2 2023.
- Per Business Quant data, the three quarters before Q4 2025 came in at $1.11 million (Q3 2025), $3.62 million (Q2 2025) and $3.74 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 43.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 6.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 9.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 47.70 Mn |
| 10 | In8Bio | 25.89 Mn | 25.89 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 10.04 Mn |
| Sep 30, 2025 | 1.11 Mn |
| Jun 30, 2025 | 3.62 Mn |
| Mar 31, 2025 | 3.74 Mn |
| Dec 31, 2024 | 6.22 Mn |
| Sep 30, 2024 | -3.62 Mn |
| Jun 30, 2024 | 3.53 Mn |
| Dec 31, 2023 | 63,000.00 |
| Sep 30, 2023 | 1.89 Mn |
| Jun 30, 2023 | 11.71 Mn |
| Mar 31, 2023 | 722,000.00 |
| Dec 31, 2022 | 44,000.00 |
| Jun 30, 2022 | 28,000.00 |
| Mar 31, 2022 | 33,000.00 |
| Sep 30, 2021 | 36.33 Mn |
| Dec 31, 2020 | 51,000.00 |
| Sep 30, 2020 | 248,000.00 |
API Access
In8Bio Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=INAB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "INAB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=INAB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();